Is N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide? Is N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide safe for nursing mother and child? Does N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide extracts into breast milk? Does N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide has any long term or short term side effects on infants? Can N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide influence milk supply or can N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide decrease milk supply in lactating mothers?
Answer by DrLact: About N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide usage in lactation
No information is available on the clinical use of N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide during breastfeeding. Because N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide is 97% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is about 28 days and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide therapy.
Alternate Drugs
Imatinib(Unsafe)
Ipilimumab(Unsafe)
Cisplatin(Unsafe)
Cetuximab(Unsafe)
Busulfan(Dangerous)
Nivolumab(Unsafe)
Azelaic Acid(Safe)
Carboplatin(Dangerous)
Vinblastine(Dangerous)
Paclitaxel(Dangerous)
Bleomycin(Dangerous)
Cladribine(Dangerous)
Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Rituximab(Low Risk)
Vincristine(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Tamoxifen(Dangerous)
Gemcitabine(Dangerous)
Thioguanine(Dangerous)
Mitoxantrone(Dangerous)
Dactinomycin(Dangerous)
Mercaptopurine(Safe)
Letrozole(Dangerous)
Erlotinib(Unsafe)
Nilotinib(Unsafe)
Exemestane(Dangerous)
Hydroxyurea(Low Risk)
Trastuzumab(Unsafe)
Etoposide(Dangerous)
Docetaxel(Dangerous)
Doxorubicin(Dangerous)
Pazopanib(Unsafe)
Cyclophosphamide(Dangerous)
Allopurinol(Safe)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Gemcitabine(Dangerous)
Erlotinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)